Problems with quality management, data integrity, expired raw materials and more have prompted the European Medicines Agency (EMA) to put the kibosh on manufacturing at Serra Pamies’ Reus, Spain, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback